What Researchers Did
Researchers conducted a systematic review of medical literature to create a guide for diagnosing, classifying, and treating severe eye and brain complications caused by dermal fillers.
What They Found
The review identified that neurological complications, including stroke, occur in up to 24% of cases of filler-induced ophthalmic vascular occlusion. Hyaluronidase remains the only intervention consistently associated with improved outcomes, though its optimal delivery route is still debated. Hyperbaric oxygen is listed as an adjunctive measure alongside other therapies.
What This Means for Canadian Patients
Canadian patients considering dermal fillers should be aware of the rare but serious risks of vascular occlusion, which can lead to vision loss or stroke. Early recognition and immediate treatment with hyaluronidase are crucial for managing these emergencies. While hyperbaric oxygen is mentioned as an additional therapy, its specific role and effectiveness in these cases require further clarification.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The review highlights that the optimal delivery route for hyaluronidase remains debated, indicating a lack of definitive evidence for this key treatment.